Wenbo Nie

Wenbo Nie


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
WZWanting Zu
Wanting Zu
XHXuemiao Huang
Xuemiao Huang
TXTianxin Xu
Tianxin Xu
LDLin Du
Lin Du
YWYiming Wang
Yiming Wang
WNWenbo Nie
Wenbo Nie
Objective: This review aimed to summarize the use of machine learning for predicting the potential benefits of stroke rehabilitation treatments, to evaluate the risk of bias of predictive models, and to provide recommendations for future models. Materials and methods: This systematic review was conducted in accordance with the PRISMA statement and the CHARMS checklist. The PubMed, Embase, Cochrane Library, Scopus, and CNKI databases were searched up to April 08, 2023. The PROBAST tool was used to assess the risk of bias of the included models. Results: Ten studies within 32 models met our inclusion criteria. The optimal AUC value of the included models ranged from 0.63 to 0.91, and the optimal R2 value ranged from 0.64 to 0.91. All of the included models were rated as having a high or unclear risk of bias, and most of them were downgraded due to inappropriate data sources or analysis processes. Discussion and conclusion: There remains much room for improvement in future modeling studies, such as high-quality data sources and model analysis. Reliable predictive models should be developed to improve the efficacy of rehabilitation treatment by clinicians.

8 October 2024 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
WZWanting Zu
Wanting Zu
SZShiyun Zhang
Shiyun Zhang
LDLin Du
Lin Du
XHXuemiao Huang
Xuemiao Huang
WNWenbo Nie
Wenbo Nie
LWLisheng Wang
Lisheng Wang
The treatment of diabetes distress plays an important role in diabetes care; however, no meta-analysis has been performed to synthesize the short- and long-term effects of psychological interventions tailored for diabetes distress in people with type 2 diabetes. We aim to evaluate the evidence on tailored psychological interventions for diabetes distress as the primary outcome, focusing on individuals with type 2 diabetes. Two reviewers independently searched eight databases from their inception to September 2024. EndNote X9 was used to screen records. The Revised Cochrane risk-of-bias tool for randomized trials was used to assess the risk of bias. The GRADE system was used to assess the overall certainty of the evidence. A random effect model was used to determine the mean difference or standardized mean difference with 95% CIs. Subgroup analyses based on several intervention characteristics and sensitivity analyses were also conducted. Totally, 22,279 records were yielded, and we finally included 18 studies in our systematic review. The meta-analysis included data from 16 studies representing 1639 participants. Interventions types included mindfulness-based and cognitive behavioral therapy, among others. Duration of interventions ranged from 4 weeks to 6 months. We found that psychological interventions that measured diabetes distress significantly reduced diabetes distress in the short-term in people with type 2 diabetes (SMD= -0.56; 95% CI= -0.90, -0.22; p = 0.001). Subgroup analysis indicated that this effect could be enhanced when delivered in a group format, by psychologist, using a technology component, or including participants having elevated baseline diabetes distress. However, the short- and long-term effects on HbA1c were non-significant, with results showing (MD = 0.02; 95% CI = -0.23 to 0.26; p = 0.89) and (MD = -0.27; 95% CI = -0.64 to 0.10; p = 0.15), respectively. The long-term effect on diabetes distress was also non-significant (SMD = -0.45; 95% CI = -0.93 to 0.03; p = 0.07). Psychological interventions tailored for diabetes distress in people with type 2 diabetes are effective in reducing the level of diabetes distress immediately after the intervention. More trials are still needed to further enrich the evidence in this area.

1 November 2021 in International Journal of Nursing Studies
Verified
Journal Article
Closed access
WYWenwen Yang
Wenwen Yang
WNWenbo Nie
Wenbo Nie
XZXue Zhou
Xue Zhou
WGWenjie Guo
Wenjie Guo
JMJingjing Mou
Jingjing Mou
XLXinmei Liu
Xinmei Liu

17 December 2023 in Cancers
Verified
Journal Article
Open access
PDF file
YWYiming Wang
Yiming Wang
LTLv Tian
Lv Tian
XLXia Liu
Xia Liu
HZHao Zhang
Hao Zhang
YTYongchun Tang
Yongchun Tang
LWLisheng Wang
Lisheng Wang
Cancer-related fatigue (CRF) is a widespread symptom with high prevalence in cancer patients, seriously affecting their quality of life. In the context of precision care, constructing machine learning-based prediction models for early screening and assessment of CRF is beneficial to this situation. To further understand the predictors of CRF for model construction, we conducted a comprehensive search in PubMed, Web of Science, Embase, and Scopus databases, combining CRF with predictor-related terms. A total of 27 papers met the inclusion criteria. We evaluated the above studies into three subgroups following the predisposing, precipitating, and perpetuating (3P) factor model. (1) Predisposing factors—baseline fatigue, demographic characteristics, clinical characteristics, psychosocial traits and physical symptoms. (2) Precipitating factors—type and stage of chemotherapy, inflammatory factors, laboratory indicators and metabolic changes. (3) Perpetuating factors—a low level of physical activity and poorer nutritional status. Future research should prioritize large-scale prospective studies with emerging technologies to identify accurate predictors of CRF. The assessment and management of CRF should also focus on the above factors, especially the controllable precipitating factors, to improve the quality of life of cancer survivors.

10 January 2023 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
LDLin Du
Lin Du
JDJunjia Du
Junjia Du
MYMin Yang
Min Yang
QXQinqin Xu
Qinqin Xu
JHJiannan Huang
Jiannan Huang
LZLijing Zhao
Lijing Zhao

8 July 2022 in Medicine
Verified
Journal Article
Open access
XHXuemiao Huang
Xuemiao Huang
TWTaiwei Wang
Taiwei Wang
WZWanting Zu
Wanting Zu
TXTianxin Xu
Tianxin Xu
LDLin Du
Lin Du
LWLisheng Wang
Lisheng Wang
Background: Graft-versus-host disease (GVHD) is a fatal complication of hematopoietic stem cell transplantation and is an enormous burden on the patient economy and related health systems. Nevertheless, only a few bibliometric studies have examined the direction of research and the major findings within the field. Methods: Statistical and visualization bibliometric analysis was performed in April 2021. Our research data were retrieved from the Web of Science using an advanced search strategy. We then used bibliometric analysis to determine the current general research direction and trend of publications and established the most prolific and distinguished authors, institutions, countries, funding agencies, and keywords in GVHD research. We employed VOSviewer (Leiden University, Leiden, Netherlands), Microsoft Excel (Microsoft, Redmond, State of Washington), and GunnMap (https://lert.co.nz/map/) to retrieve, integrate, and visualize the results. Results: Overall, 15,378 publications from 500 journals were extracted from the Institute for Scientific Information (ISI) Web of Science Core Collection database based on our analysis, of which the United States and the Fred Hutchinson Cancer Research Center were the most prolific countries and institutions, respectively. Moreover, we identified future research trends and the current status of GVHD research based on the top 10 most cited articles. Finally, influential authors’ analysis demonstrated that Blazar, BR were both the most productive and most cited among all authors. Conclusion: Our study provides an exhaustive and objective overview of the current status of GVHD research. This information would be highly beneficial to anyone seeking information on GVHD and would serve as a reference guide for researchers aiming to conduct further GVHD research.